跳转至内容
Merck
CN

O-002

羟考酮标准液 溶液

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

登录 查看公司和协议定价

选择尺寸

关于此项目

经验公式（希尔记法）:
C18H21NO4
化学文摘社编号:
76-42-6
分子量:
315.36
EC 号:
200-659-6
MDL编号:
MFCD00190613
UNSPSC代码:
41116107
PubChem化学物质编号:
329818811
NACRES:
NA.24

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

等级

certified reference material

质量水平

300

表单

liquid

特点

Snap-N-Spike®/Snap-N-Shoot®

包装

ampule of 1 mL

制造商/商品名称

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)
kontrollierte Droge in Deutschland

浓度

1.0 mg/mL in methanol

技术

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

应用

forensics and toxicology

包装形式

single component solution

储存温度

2-8°C

SMILES字符串

COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O

InChI

1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1

InChI key

BRUQQQPBMZOVGD-XFKAJCMBSA-N

基因信息

human ... OPRM1(4988)

正在寻找类似产品? 访问 产品对比指南

相关类别

一般描述

该认证的加标溶液®适用于从临床毒理学和尿液药物测试到法医分析的羟考酮GC/MS或LC/MS测试的许多应用。羟考酮是一种半合成阿片类镇痛药，以许多商品名出售，包括OxyContin®和Percocet®，用于治疗中度至重度疼痛。羟考酮还以“Roxies”，“Blues”和“Perks”等街头名称非法出售。

其他说明

在我们的NMR在线平台ChemisTwin®上可以找到本品对应的数字化标准物质。您可使用ChemisTwin®上的数字等效品鉴定您的样品并进行定量分析（使用数字化外标）。可查看该物质的NMR谱图，只需点击几次鼠标，就能进行在线样品比对。欢迎点击了解更多，开启免费试用之旅。

法律信息

German
Dieses Produkt fällt unter das Betäubungsmittelgesetz (BtMG). Für eine Bestellung dieses Produktes ist eine Erlaubnis nach § 3 BtMG zwingend erforderlich, es sei denn, es greift eine Ausnahme von der Erlaubnispflicht nach § 4 oder § 26 BtMG.

English
This product is subject to the German Narcotics Act. A permit under Section 3 of the German Narcotics Act is mandatory for ordering this product unless an exemption from the permit requirement under Section 4 or Section 26 of the German Narcotics Act applies.
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
OxyContin is a registered trademark of Purdue Pharma L.P.
Percocet is a registered trademark of Endo Pharmaceuticals Inc.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

警示用语：

Danger

危险分类

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

靶器官

Eyes,Central nervous system

储存分类代码

3 - Flammable liquids

WGK

WGK 2

闪点(°F)

49.5 °F - closed cup

闪点(°C)

9.7 °C - closed cup

法规信息

监管及禁止进口产品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Kenneth Kirsh et al.
Journal of pain & palliative care pharmacotherapy, 26(4), 348-361 (2013-05-16)
Prescription opioids are prescribed increasingly for the management of chronic pain, and this has been accompanied by a dramatic rise in opioid-related abuse, addiction, and overdose deaths. Reports of abuse involving nonoral administration (e.g., snorting, injecting) of prescription opioids are
Sanjay Merchant et al.
Journal of opioid management, 9(1), 51-61 (2013-05-28)
To evaluate a composite measure for chronic pain that balances pain relief with tolerability. Post hoc meta-analysis of three randomized, multicenter, double-blind studies. Subjects with moderate-to-severe chronic osteoarthritis knee pain or low back pain who had been randomized to receive
Myoung Kim et al.
Journal of opioid management, 9(3), 189-204 (2013-06-19)
This article describes the rationale and design of the Oxycodone Users Registry (OUR) study and lessons learned during study development and data collection. The OUR study used a prospective registry design. Sixty-five academic and private medical practices across the United
FDA ban of generic oxycodone calls into question Health Canada's approval.
Adam Miller
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 185(9), E381-E382 (2013-05-01)
Opioid abuse.
Joel Lexchin
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 185(5), 418-418 (2013-03-20)
查看所有相关文献

商品

Benefits of Ascentis Express Phenyl-Hexyl over Biphenyl for the Separation of Pain Management Opiates

Although both biphenyl and phenyl-hexyl phases can resolve these compounds, the former exhibits excellent peak shape and substantially less silanol-derived ion exchange activity.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持